PROM1 and small cell lung carcinoma: We previouslyexplored the potential of CD133 as a biomarker for the early diagnosisand molecular imaging of patients with SCLC.17 We found that CD133 is significantly overexpressed in patients withSCLC and that the expression rate of the protein does not vary withthe stage of the disease.